2019
DOI: 10.1016/j.jtcvs.2018.08.085
|View full text |Cite
|
Sign up to set email alerts
|

Risk factors for paravalvular leak after transcatheter aortic valve replacement

Abstract: Objective. To assess risk factors for paravalvular leak (PVL) after transcatheter aortic valve implantation (TAVI) in a large single-center cohort, including measurement of aortic valve calcification using a reproducible method. Methods. We retrospectively analyzed preoperative contrast-enhanced multidetector computed tomography (MDCT) scans of patients who underwent TAVI in our center between 2009 and 2016. Calcium volume was calculated for each aortic cusp in the aortic valve (AV), left ventricular outflow t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

2
33
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 55 publications
(35 citation statements)
references
References 19 publications
2
33
0
Order By: Relevance
“…Technological developments in TAVI technology include the introduction of a polyethylene terephthalate outer skirting in the SAPIEN 3 prosthesis (Edwards Lifesciences, Irvine, California) with the goal of increasing contact and adhesion of the valve against the aortic annulus (50). Clinical results suggest that the SAPIEN 3 prosthesis is associated with a lower incidence of paravalvular leak compared to SAPIEN XT (Edwards Lifesciences) and CoreValve EvolutR (Medtronic, Minneapolis, Minnesota) (51). Future larger studies with longer follow-up will be required to demonstrate whether these differences have a significant clinical effect.…”
Section: Discussionmentioning
confidence: 99%
“…Technological developments in TAVI technology include the introduction of a polyethylene terephthalate outer skirting in the SAPIEN 3 prosthesis (Edwards Lifesciences, Irvine, California) with the goal of increasing contact and adhesion of the valve against the aortic annulus (50). Clinical results suggest that the SAPIEN 3 prosthesis is associated with a lower incidence of paravalvular leak compared to SAPIEN XT (Edwards Lifesciences) and CoreValve EvolutR (Medtronic, Minneapolis, Minnesota) (51). Future larger studies with longer follow-up will be required to demonstrate whether these differences have a significant clinical effect.…”
Section: Discussionmentioning
confidence: 99%
“…Fifth, we did not quantify the degree of aortic calcification. Postdilatation was more often performed in patients with high calcium degree, resulting in higher incidences of paravalvular leakage and atrioventricular block 25 . Furthermore, patients with larger recoil tended to have a greater Agatston calcium scores 17 .…”
Section: Discussionmentioning
confidence: 99%
“…Postdilatation was more often performed in patients with high calcium degree, resulting in higher incidences of paravalvular leakage and atrioventricular block. 25 Furthermore, patients with larger recoil tended to have a greater Agatston calcium scores. 17 Calcium amount could be a confounder for the recoil effect observed in our study.…”
Section: Limitationsmentioning
confidence: 97%
“…Although there were no significant differences in baseline characteristics, including surgical risk scores, observational studies inherently include a risk of confounding variables. For example, PVL is influenced by many factors such as the type of prosthesis used, differences in procedural technique and center experience [29] . However, mode of anesthesia is the most concerning confounding variable.…”
Section: Limitationsmentioning
confidence: 99%